| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |